Systematic Review and Meta-Analysis of the Efficacy and Safety of Novel Monoclonal Antibodies for Treatment of Relapsed/Refractory Multiple Myeloma

Oncotarget - United States
doi 10.18632/oncotarget.16987
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Arsenic Trioxide-Based Therapy in Relapsed/Refractory Multiple Myeloma Patients: A Meta-Analysis and Systematic Review

OncoTargets and Therapy
OncologyPharmacology
2014English

Correction: Management of Relapsed and Refractory Multiple Myeloma: Novel Agents, Antibodies, Immunotherapies and Beyond

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2019English

Efficacy and Safety of Long-Term Treatment With Lenalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2014English

Psy73 - Economic and Social Burden of Relapsed or Refractory Multiple Myeloma: A Systematic Review of the Literature

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Daratumumab vs. Pomalidomide for the Treatment of Relapsed/Refractory Multiple Myeloma: A Cost‐effectiveness Analysis

American Journal of Hematology
Hematology
2018English

The Efficacy and Safety of Tigecycline for the Treatment of Bloodstream Infections: A Systematic Review and Meta-Analysis

Annals of Clinical Microbiology and Antimicrobials
MedicineInfectious DiseasesMicrobiology
2017English

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory T(11;14) Multiple Myeloma

British Journal of Haematology
Hematology
2020English

Carfilzomib for Relapsed or Refractory Multiple Myeloma

The Lancet Oncology
Oncology
2018English

Current Use of Monoclonal Antibodies in the Treatment of Multiple Myeloma

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy